Patent US5283255A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5283255A Expired / Lapsed US ⏱️ 0.0 years remaining

Wavelength-specific cytotoxic agents

Assignee: University of British Columbia
•
Filing: 1992-09-11
•
Granted: 1994-02-01
•
Expires: 2012-09-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A group of hydro-monobenzoporphyrins "green porphyrins" (Gp) having absorption maxima in the range of 670-780 nanometers is useful in treating disorders or conditions which are subject to hematoporphyrin derivative (HPD) treatment in the presence of light, or in treating virus, cells and tissues generally to destroy unwanted targets. The use of the Gp of the invention permits the irradiation for therapy to use wavelengths other than those absorbed by blood. The Gp of the invention may also be conjugated to ligands specific for receptor or to specific immunoglobulins or fragments thereof to target specific tissues or cells for the radiation treatment. Use of these materials permits lower levels of drug to be used, thus preventing side reactions which might destroy normal tissues.

Inventors

  • 👤 Julia G. Levy
  • 👤 David Dolphin
  • 👤 Jack J. Chow
  • 👤 Ethan Sternberg

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 13:43
CPC Classifications
A; A61; A61K; A61K41/00; A61K41/0057; A61K41/0071; A61K49/00; A61K49/001; A61K49/0013; A61K49/0017; A61K49/0019; A61K49/0021; A61K49/0036; A61K51/00; A61K51/02; A61K51/04; A61K51/0474; A61K51/0485; A61K51/08; A61K51/10; A61K51/1093; C; C07; C07D; C07D487/00; C07D487/22; C07D519/00; A61K2121/00

Claims Analysis

Total Claims: 27
Claim 1
Independent Claim 335 words
A method to detect, photosensitize, destroy or impair the functioning of target biological material which comprises contacting said target with an effective amount of a hydro-monobenzoporphyrin (Gp) having a light absorption maximum between 670-780 nm; wherein the Gp is selected from the group consisting of ##STR17## and mixtures thereof and the metalated and labeled forms thereof, wherein each R 1 and R 2 independently selected from the group consisting of carbalkoxy (2-6C), alkyl (1-6C) sulfonyl, Aryl (6-10C) sulfonyl, aryl (6-10C); cyano; and --CONR 5 CO-- wherein R 5 is aryl (6-10C) or alkyl (1-6C) each R 3 is independently carboxyalkyl (2-6C) or a salt, amide, ester or acylhydrazone thereof, or is alkyl (1-6C); and R 4 is CHCH 2 , CH 2 OR 4' , --CHO, --COOR 4 CH(OR 4' )CH 3 , CH(OR 4' )CH 2 OR 4' , --CH(SR 4' )CH 3 , --CH(NR 2 )CH 3 , --CH(CN)CH 3 , --CH(COOR 4' )CH 3 , --CH((OOCR 4' )CH 3 , --CH(halo)CH or --CH(halo)CH 2 (halo), wherein R 4' is H, alkyl (1-6C) optionally substituted with a hydrophilic substituent, or wherein R 4 is an organic noninterfering group of <12C resulting from direct or indirect derivatization of vinyl, or wherein R 4 consists of 1-3 tetrapyrrole-type nuclei of the formula --L--P wherein --L-- is selected from the group consisting of ##STR18## and P is selected from the group consisting of Gp which is of the formula 1-6 but lacking R 4 and conjugated through the position shown as occupied by R 4 to L, and a porphyrin of the formula: ##STR19## wherein each R is independently H or lower alkyl (1-4C); wherein two of the bonds shown as unoccupied on adjacent rings are joined to R 3 and one of the remaining bonds shown as unoccupied is joined to R 4 and the other to L; with the proviso that if R 4 is CHCH 2 , both R 3 cannot be carbalkoxyethyl; and irradiating said target with light absorbed by said Gp.
Claim 2
Independent Claim 335 words
A method to detect, photosensitize, destroy or impair the functioning of target biological material which comprises contacting said target with an effective amount of a hydro-monobenzoporphyrin (Gp) having a light absorption maximum between 670-780 nm; wherein the Gp is selected from the group consisting of ##STR17## and mixtures thereof and the metalated and labeled forms thereof, wherein each R 1 and R 2 independently selected from the group consisting of carbalkoxy (2-6C), alkyl (1-6C) sulfonyl, Aryl (6-10C) sulfonyl, aryl (6-10C); cyano; and --CONR 5 CO-- wherein R 5 is aryl (6-10C) or alkyl (1-6C) each R 3 is independently carboxyalkyl (2-6C) or a salt, amide, ester or acylhydrazone thereof, or is alkyl (1-6C); and R 4 is CHCH 2 , CH 2 OR 4' , --CHO, --COOR 4 CH(OR 4' )CH 3 , CH(OR 4' )CH 2 OR 4' , --CH(SR 4' )CH 3 , --CH(NR 2 )CH 3 , --CH(CN)CH 3 , --CH(COOR 4' )CH 3 , --CH((OOCR 4' )CH 3 , --CH(halo)CH or --CH(halo)CH 2 (halo), wherein R 4' is H, alkyl (1-6C) optionally substituted with a hydrophilic substituent, or wherein R 4 is an organic noninterfering group of <12C resulting from direct or indirect derivatization of vinyl, or wherein R 4 consists of 1-3 tetrapyrrole-type nuclei of the formula --L--P wherein --L-- is selected from the group consisting of ##STR18## and P is selected from the group consisting of Gp which is of the formula 1-6 but lacking R 4 and conjugated through the position shown as occupied by R 4 to L, and a porphyrin of the formula: ##STR19## wherein each R is independently H or lower alkyl (1-4C); wherein two of the bonds shown as unoccupied on adjacent rings are joined to R 3 and one of the remaining bonds shown as unoccupied is joined to R 4 and the other to L; with the proviso that if R 4 is CHCH 2 , both R 3 cannot be carbalkoxyethyl; and irradiating said target with light absorbed by said Gp.
Claim 3
Independent Claim 23 words
The method of claim I wherein each R 3 is --CH 2 CH 2 COOH or a salt, amide, ester or acylhydrazone thereof.
Claim 4
Dependent Claim 16 words
The method of claim 1 wherein each of R 1 and R 2 is carbalkoxy (2-6C).
Claim 5
Dependent Claim 16 words
The method of claim 2 wherein each of R 1 and R 2 is carbalkoxy (2-6C).
Claim 6
Dependent Claim 13 words
The method of claim 1 wherein the Gp has formula 3 or 4.
Claim 7
Dependent Claim 13 words
The method of claim 4 wherein the Gp has formula 3 or 4.
Claim 8
Dependent Claim 144 words
The method of claim 1 wherein the Gp has formula 3 or 4 and mixtures thereof, and wherein each R 1 and R 2 independently selected from the group consisting of carbalkoxy (2-6C), alkyl (1-6C) sulfonyl, aryl (6-10C) sulfonyl, aryl (6-10C) cyano; and --CONR 5 CO-- wherein R 5 is aryl (6-10C) or alkyl (1-6C); each R 3 is independently carboxyalkyl (2-6C) or a salt, amide, ester or acylhydrazone thereof, or is alkyl (1-6C); R 4 is CHCH 2 CH 2 OR 4' , --CHO, --COOR 4' , CH(OR 4' )CH 3 , CH(OR 4' )CH 2 OR 4' , --CH(SR 4' )CH 3 , --CH(NR 4' 2 )CH 3 , --CH(CN)CH 3 , --CH(COOR 4' )CH 3 , --CH((OOCR 4' )CH 3 , --CH(halo)CH 3 , or --CH(halo)CH 2 (halo), wherein R 4' is H, alkyl (1-6C) optionally substituted with a hydrophilic substituent.
Claim 9
Dependent Claim 92 words
The method of claim 1 wherein the Gp has formula 3 or 4 and mixtures thereof, and wherein each R 1 and R 2 is independently selected from the group consisting of carbalkoxy, alkyl (1-6C) sulfonyl, aryl (6-10C) sulfonyl, aryl (6-10C) cyano; and --CONR 5 CO-- wherein R 5 is aryl (6-10C) or alkyl (1-6C); each R 3 is independently carboxyalkyl (2-6C) or a salt, amide, ester or acylhydrazone thereof, or is alkyl (1-6C); and wherein R 4 is a substituent containing 1-3 tetrapyrrole-type nuclei, of the formula --L--P as herein defined.
Claim 10
Dependent Claim 34 words
The method of claim 1 wherein the target materials are cells or tissue harbored in a subject and said contacting comprises administering the Gp in vivo to said subject harboring said cells or tissue.
Claim 11
Dependent Claim 13 words
The method of claim 9 wherein the administering is by an oral route.
Claim 12
Dependent Claim 10 words
The method of claim 9 wherein the administering is topical.
Claim 13
Dependent Claim 11 words
The method of claim 9 wherein the administering is by injection.
Claim 14
Dependent Claim 12 words
The method of claim 9 wherein the Gp further contains a label.
Claim 15
Dependent Claim 19 words
The method of claim 13 wherein the label is selected from the group consisting of technetium, gallium and indium.
Claim 16
Dependent Claim 14 words
The method of claim 1 wherein the target is contained in a biological fluid.
Claim 17
Dependent Claim 14 words
The method of claim 15 wherein the biological fluid is blood or blood plasma.
Claim 18
Dependent Claim 12 words
The method of claim 16 wherein the fluid is treated ex vivo.
Claim 19
Dependent Claim 33 words
The method of claim 1 wherein said method is to photosensitize, destroy or impair the functioning of target biological material, and where said irradiating is conducted with light of wavelength between 670-780 nm.
Claim 20
Dependent Claim 13 words
The method of claim 18 wherein said irradiation is supplied by a laser.
Claim 21
Dependent Claim 14 words
The method of claim 18 wherein said irradiation is supplied by a light-emitting diode.
Claim 22
Dependent Claim 14 words
The method of claim 1 wherein the target material is the lesions of psoriasis.
Claim 23
Dependent Claim 12 words
The method of claim 1 wherein the target material is atherosclerotic plaque.
Claim 24
Dependent Claim 12 words
The method of claim 1 wherein the target material is a virus.
Claim 25
Dependent Claim 23 words
The method of claim 1 which is to detect the target biological material and wherein said irradiating excites said Gp to emit fluorescence.
Claim 26
Dependent Claim 57 words
A method to detect or impair the metabolism of or to effect the destruction of target virus, cells, or tissues which comprises contacting said target with an effective amount of the Gp compound as defined in claim 1, or a pharmaceutical composition thereof, and irradiating the contacted virus, cells, or tissues with light absorbed by the Gp.
Claim 27
Dependent Claim 19 words
The method of claim 25 wherein the target comprises cells selected from tumor cells, T-suppressor cells and infective cells.

References Cited (Backward Citations)

US4649151A Cited
US4883790A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-01-31 1997-08-02 1998-02-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-01-31 2001-08-02 2002-02-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-01-31 2005-08-02 2006-02-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag